{"id":3451,"date":"2023-02-06T16:21:29","date_gmt":"2023-02-06T16:21:29","guid":{"rendered":"https:\/\/bxta.com\/?p=3451"},"modified":"2023-02-06T16:21:31","modified_gmt":"2023-02-06T16:21:31","slug":"prostate-cancer-patient-angus-watson","status":"publish","type":"post","link":"https:\/\/bxta.com\/de\/prostate-cancer-patient-angus-watson\/","title":{"rendered":"Prostate Cancer Patient: Angus Watson"},"content":{"rendered":"

<\/p>\n\n\n\n

Prostate cancer is the most common cancer in men in the United Kingdom, affecting nearly 50,000 men a year. During the peak of COVID-19, between March and September 2020, urgent referrals for suspected cancer were down by 31%<\/a> compared to the same period in 2019, equating to 42,000 fewer people. It\u2019s clear that many patients are not being diagnosed \u2013 and may not even show symptoms \u2013 yet, an early diagnosis can help not only increase survival rates, but also offer a more varied choice of treatments with improved quality of life.

<\/p>\n\n\n\n

Angus Watson, a 61-year-old man from Scotland, did not show any symptoms of prostate cancer. In fact, he only went to his local GP back in 2020 due to having signs of a hernia. However, his doctor, who was in training at the time, asked him whether he had any family history of prostate complications \u2013 and this is when he revealed that his close relative had prostate cancer.

<\/p>\n\n\n\n

Once the trainee-GP found out about Angus\u2019 family history, he advised him to undertake a prostate-specific antigen (PSA) blood test, which came back with a low-borderline score of 2.66ng\/ml. Typically, levels over 4 ng\/ml are considered abnormal, but Angus\u2019 doctor was keen for him to undergo further testing due to his family member\u2019s prostate cancer: \u201cI was very fortunate that I had a doctor who listened and had the time to pay attention to me, rather than pushing me out the door and instead, monitoring my prostate levels.\u201d

<\/p>\n\n\n\n

At this time, COVID-19 was at its peak \u2013 with the NHS under unprecedented pressure, while GP consultations dropped by 30%<\/a>. However, the pandemic didn\u2019t put Angus off progressing in getting tested: \u201cI was willing to go to the hospital, as well as the GP, despite the pandemic. At the time, COVID infection rates and hospital admissions were fairly low, so the timing worked in my favour, but I didn\u2019t want it to stop me from checking my own health.\u201d

<\/p>\n\n\n\n

In early 2021, Angus, who was living in Dorset during his diagnosis, went to Dorchester Hospital to have his biopsy undertaken. Of 30 samples taken 17 were found to contain cancerous cells, with a Gleason Score of 3+4, which qualifies as a \u201cgood prognosis\u201d. Due to his prostate cancer being found early, Angus\u2019 cancer was well contained in the prostate, and in turn, he was diagnosed with stage two prostate cancer.

<\/p>\n\n\n\n

As his first consultation post-diagnosis, Angus was referred to a consultant surgeon and was advised to go down the same route as his relative \u2013 a prostatectomy. Angus explains: \u201cBecause the surgeon had done the biopsy, surgery was the first route I was offered, and because they are the experts, I decided in my head that this must be the best pathway for me.\u201d

<\/p>\n\n\n\n

However, due to the COVID-19 backlog and his low-level diagnosis, Angus was subsequently referred to a consultant urologist to discuss other treatment options. During these consultations, the multi-disciplinary urology team discussed various treatments with him, and recommended LDR brachytherapy: \u201cThey said that brachytherapy was the perfect solution for me, which I agreed with as it\u2019s a focal therapy that targets the cancer cells locally.\u201d

<\/p>\n\n\n\n

\u201cThe consultants also emphasised the importance for me to know my options and to make the best decision \u2013 rather than going to the first one I hear, which is what I nearly did. I almost ran the risk of having significant side effects from surgery, which I haven\u2019t had with brachytherapy.\u201d

<\/p>\n\n\n\n

Angus had his brachytherapy treatment at Poole Hospital, which he described as \u201cvery straightforward and painless.\u201d He said: \u201cI said to the nurses, I\u2019m not even sure you\u2019ve done anything. I stayed overnight, and I was back home the next day. The brachytherapy team at Poole Hospital were phenomenal, they were also checking that I was okay.\u201d

<\/p>\n\n\n\n

Since his treatment, Angus has not suffered from any side effects \u2013 apart from having to occasionally get up in the night to go to the toilet. He has had three PSA tests since his treatment, where his levels continue to drop. \u201cThe last one I had was at the beginning of March, and the doctor said to me, \u201cIt doesn\u2019t get any better than this\u201d so that\u2019s a really good result.\u201d Angus\u2019 next PSA test will be in six months and will continue to be monitored for the next five years.

<\/p>\n\n\n\n

Following his prostate cancer journey, Angus now encourages his friends and family to keep an eye on their health \u2013 and emphasises the need for them to get checked. \u201cBecause I had no symptoms, if I hadn\u2019t gone to the doctor with my hernia in 2020, it struck me that I could have had much more aggressive prostate cancer, but I caught it early. My message to men is that you don\u2019t necessarily need to have symptoms to get checked.\u201d

<\/p>\n\n\n\n

Additionally, compared to other cancers, such as bowel cancer and breast cancer, there is no \u2018mandatory screening method\u2019 for prostate cancer, which Angus highlighted needs to change. \u201cI know it\u2019s not straightforward, and a lot of things can affect your PSA, but if a gentleman over 50 gets his PSA checked every six months, doctors can start to see trends and spot any warning signs earlier. Please make sure you get it done, and then tell them you want another one in six months, even if it was a low score.\u201d

<\/p>\n\n\n\n

Particularly getting diagnosed and treated over the pandemic, Angus comments: \u201cWe\u2019re seeing on TV all the time the pressures NHS staff are under. And if men, like me, haven\u2019t got any symptoms, it\u2019s easy to think that there are other people who are a much higher priority, and to not \u2018bother\u2019 healthcare professionals. But all we\u2019re doing is delaying a much larger challenge for the NHS, because the longer men leave it \u2013 the more delayed and aggressive cancer can become \u2013 which in turn, will be a much bigger and expensive challenge to solve long term.\u201d

<\/p>\n\n\n\n

Commenting on his LDR brachytherapy experience, Angus concludes: \u201cBrachytherapy worked really well for me. It was painless, straightforward and it seems to have sorted me out. My main piece of advice is to not make a decision based on the first answer or treatment option you discuss. Make sure you do your homework and speak to various professionals.\u201d

<\/p>\n\n\n\n

ENDS<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

Prostate cancer is the most common cancer in men in the United Kingdom, affecting nearly 50,000 men a year. During the peak of COVID-19, between March and September 2020, urgent referrals for suspected cancer were down by 31% compared to the same period in 2019, equating to 42,000 fewer people. It\u2019s clear that many patients […]<\/p>\n","protected":false},"author":10,"featured_media":3038,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"template-old-blog.php","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[5,1],"tags":[],"class_list":["post-3451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patient-stories","category-uncategorized"],"acf":[],"yoast_head":"\nProstate Cancer Patient: Angus Watson - BXTA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bxta.com\/de\/prostate-cancer-patient-angus-watson\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prostate Cancer Patient: Angus Watson - BXTA\" \/>\n<meta property=\"og:description\" content=\"Prostate cancer is the most common cancer in men in the United Kingdom, affecting nearly 50,000 men a year. During the peak of COVID-19, between March and September 2020, urgent referrals for suspected cancer were down by 31% compared to the same period in 2019, equating to 42,000 fewer people. It\u2019s clear that many patients […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bxta.com\/de\/prostate-cancer-patient-angus-watson\/\" \/>\n<meta property=\"og:site_name\" content=\"BXTA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bxtainternational\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-06T16:21:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-06T16:21:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bxta.com\/wp-content\/uploads\/2021\/09\/blog-image-09.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"311\" \/>\n\t<meta property=\"og:image:height\" content=\"418\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing BXTA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BXTA_\" \/>\n<meta name=\"twitter:site\" content=\"@BXTA_\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing BXTA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/\"},\"author\":{\"name\":\"Marketing BXTA\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/person\\\/be7f4368cd4f7e11918870d00223473a\"},\"headline\":\"Prostate Cancer Patient: Angus Watson\",\"datePublished\":\"2023-02-06T16:21:29+00:00\",\"dateModified\":\"2023-02-06T16:21:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/\"},\"wordCount\":1056,\"publisher\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/blog-image-09.jpg\",\"articleSection\":[\"Patient Stories\",\"Uncategorized\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/\",\"url\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/\",\"name\":\"Prostate Cancer Patient: Angus Watson - BXTA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/blog-image-09.jpg\",\"datePublished\":\"2023-02-06T16:21:29+00:00\",\"dateModified\":\"2023-02-06T16:21:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/blog-image-09.jpg\",\"contentUrl\":\"https:\\\/\\\/bxta.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/blog-image-09.jpg\",\"width\":311,\"height\":418},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bxta.com\\\/prostate-cancer-patient-angus-watson\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bxta.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prostate Cancer Patient: Angus Watson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"name\":\"BXTA\",\"description\":\"Let\u2019s tackle Prostate Cancer together | BXTA\",\"publisher\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bxta.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\",\"name\":\"BXTA\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"contentUrl\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"width\":600,\"height\":373,\"caption\":\"BXTA\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bxtainternational\\\/\",\"https:\\\/\\\/x.com\\\/BXTA_\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bxtaccelyon\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkTU9L10CS5c1eWtGiMZ7gw\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/person\\\/be7f4368cd4f7e11918870d00223473a\",\"name\":\"Marketing BXTA\",\"url\":\"https:\\\/\\\/bxta.com\\\/de\\\/author\\\/marketingbxta\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prostate Cancer Patient: Angus Watson - BXTA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bxta.com\/de\/prostate-cancer-patient-angus-watson\/","og_locale":"de_DE","og_type":"article","og_title":"Prostate Cancer Patient: Angus Watson - BXTA","og_description":"Prostate cancer is the most common cancer in men in the United Kingdom, affecting nearly 50,000 men a year. During the peak of COVID-19, between March and September 2020, urgent referrals for suspected cancer were down by 31% compared to the same period in 2019, equating to 42,000 fewer people. It\u2019s clear that many patients […]","og_url":"https:\/\/bxta.com\/de\/prostate-cancer-patient-angus-watson\/","og_site_name":"BXTA","article_publisher":"https:\/\/www.facebook.com\/bxtainternational\/","article_published_time":"2023-02-06T16:21:29+00:00","article_modified_time":"2023-02-06T16:21:31+00:00","og_image":[{"width":311,"height":418,"url":"https:\/\/bxta.com\/wp-content\/uploads\/2021\/09\/blog-image-09.jpg","type":"image\/jpeg"}],"author":"Marketing BXTA","twitter_card":"summary_large_image","twitter_creator":"@BXTA_","twitter_site":"@BXTA_","twitter_misc":{"Verfasst von":"Marketing BXTA","Gesch\u00e4tzte Lesezeit":"5\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/#article","isPartOf":{"@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/"},"author":{"name":"Marketing BXTA","@id":"https:\/\/bxta.com\/uk\/#\/schema\/person\/be7f4368cd4f7e11918870d00223473a"},"headline":"Prostate Cancer Patient: Angus Watson","datePublished":"2023-02-06T16:21:29+00:00","dateModified":"2023-02-06T16:21:31+00:00","mainEntityOfPage":{"@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/"},"wordCount":1056,"publisher":{"@id":"https:\/\/bxta.com\/uk\/#organization"},"image":{"@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/#primaryimage"},"thumbnailUrl":"https:\/\/bxta.com\/wp-content\/uploads\/2021\/09\/blog-image-09.jpg","articleSection":["Patient Stories","Uncategorized"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/","url":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/","name":"Prostate Cancer Patient: Angus Watson - BXTA","isPartOf":{"@id":"https:\/\/bxta.com\/uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/#primaryimage"},"image":{"@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/#primaryimage"},"thumbnailUrl":"https:\/\/bxta.com\/wp-content\/uploads\/2021\/09\/blog-image-09.jpg","datePublished":"2023-02-06T16:21:29+00:00","dateModified":"2023-02-06T16:21:31+00:00","breadcrumb":{"@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/#primaryimage","url":"https:\/\/bxta.com\/wp-content\/uploads\/2021\/09\/blog-image-09.jpg","contentUrl":"https:\/\/bxta.com\/wp-content\/uploads\/2021\/09\/blog-image-09.jpg","width":311,"height":418},{"@type":"BreadcrumbList","@id":"https:\/\/bxta.com\/prostate-cancer-patient-angus-watson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bxta.com\/"},{"@type":"ListItem","position":2,"name":"Prostate Cancer Patient: Angus Watson"}]},{"@type":"WebSite","@id":"https:\/\/bxta.com\/uk\/#website","url":"https:\/\/bxta.com\/uk\/","name":"BXTA","description":"Let\u2019s tackle Prostate Cancer together | BXTA","publisher":{"@id":"https:\/\/bxta.com\/uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bxta.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/bxta.com\/uk\/#organization","name":"BXTA","url":"https:\/\/bxta.com\/uk\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/","url":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","contentUrl":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","width":600,"height":373,"caption":"BXTA"},"image":{"@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bxtainternational\/","https:\/\/x.com\/BXTA_","https:\/\/www.linkedin.com\/company\/bxtaccelyon","https:\/\/www.youtube.com\/channel\/UCkTU9L10CS5c1eWtGiMZ7gw"]},{"@type":"Person","@id":"https:\/\/bxta.com\/uk\/#\/schema\/person\/be7f4368cd4f7e11918870d00223473a","name":"Marketing BXTA","url":"https:\/\/bxta.com\/de\/author\/marketingbxta\/"}]}},"_links":{"self":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/posts\/3451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/comments?post=3451"}],"version-history":[{"count":3,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/posts\/3451\/revisions"}],"predecessor-version":[{"id":3713,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/posts\/3451\/revisions\/3713"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/media\/3038"}],"wp:attachment":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/media?parent=3451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/categories?post=3451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/tags?post=3451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}